galactosyl-(1-3)galactose has been researched along with Blood Poisoning in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bernth Jensen, JM; Ellerman-Eriksen, S; Jensenius, JC; Møller, BK; Petersen, MS; Sørensen, UBS; Thiel, S | 1 |
| Aguiar, S; Aires da Silva, F; Cardoso, S; Carlos, AR; Gjini, E; Li, H; Nuñez, G; Rebelo, S; Singh, S; Soares, MP; Sobral, D; Thompson, JA; Truglio, M; Weis, S; Yilmaz, B | 1 |
2 other study(ies) available for galactosyl-(1-3)galactose and Blood Poisoning
| Article | Year |
|---|---|
Abundant human anti-Galα3Gal antibodies display broad pathogen reactivity.
Topics: Antibodies; Disaccharides; Enzyme-Linked Immunosorbent Assay; Escherichia coli; Escherichia coli Infections; Host-Pathogen Interactions; Humans; Immunoglobulin G; Sepsis | 2020 |
Loss of α-gal during primate evolution enhanced antibody-effector function and resistance to bacterial sepsis.
Topics: Animals; Bacteria; Biological Evolution; Carrier Proteins; Disaccharides; DNA-Binding Proteins; Female; Galactosyltransferases; Glycoproteins; Hominidae; Humans; Immunoglobulin G; Male; Mammals; Mice; Mice, Knockout; Polysaccharides; Primates; Sepsis | 2021 |